Literature DB >> 9716034

What is the role of radiation-chemotherapy in the radical non-surgical management of carcinoma of the oesophagus? Upper GI Cancer Working Party of the UK Medical Research Council.

P Price1, P J Hoskin, T Hutchinson, S Stenning.   

Abstract

The optimal radical non-surgical management of carcinoma of the oesophagus has yet to be determined. The combination of high-dose radiotherapy with chemotherapy is being explored, particularly in North America. The MRC Upper GI Working Party has debated the areas where there is scientific uncertainty and which clinical trials may be appropriate to undertake in the UK.

Entities:  

Mesh：

Year:  1998        PMID： 9716034      PMCID： PMC2063077          DOI： 10.1038/bjc.1998.522

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  20 in total

1.  Study design in the evaluation of combined radiotherapy plus chemotherapy.

Authors:  J R Yarnold; P J Hoskin; S N Powell
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

2.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors:  A Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; V Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

3.  The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.

Authors:  M K Parmar; D J Spiegelhalter; L S Freedman
Journal:  Stat Med       Date:  1994 Jul 15-30       Impact factor: 2.373

4.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

5.  Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies.

Authors:  M S Bhansali; J S Vaidya; R G Bhatt; P K Patil; R A Badwe; P B Desai
Journal:  Ann Oncol       Date:  1996-04       Impact factor: 32.976

6.  Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.

Authors:  M I Saunders; S Dische; A Barrett; M K Parmar; A Harvey; D Gibson
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

7.  Chemoradiotherapy of esophageal carcinoma.

Authors:  E A Poplin; P S Khanuja; M J Kraut; A M Herskovic; P B Lattin; G Cummings; L E Gaspar; J L Kinzie; Z Steiger; V K Vaitkevicius
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

8.  Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.

Authors:  B D Minsky; D Neuberg; D P Kelsen; T M Pisansky; R Ginsberg; A Benson
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

Review 9.  Combined modality treatment with radiotherapy and chemotherapy.

Authors:  I F Tannock
Journal:  Radiother Oncol       Date:  1989-10       Impact factor: 6.280

10.  An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.

Authors:  A J Munro
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.